ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
R. L. Elliott, X. P. Jiang, C. C. Baucom
Recently there have been many advances in cancer treatment, however, treatment results would be much better if clinical oncologist s were educated on the research of cancer metabolism and basic cancer immunology. Many medical oncologists have deficiency in th…
Aziza El Ouali, Manal Azizi, Nadia Bouhafs, Mounia Rimani, Ayad Ghannam, Abdeladim Babakhouya, Maria Rkain, Noufissa Benajiba
Pyoderma gangrenosum (PG) is a rare but serious ulcerating skin disease that occurs either idiopathically or associated with various systemic diseases and malignant tumors. Although the association of PG with myeloid malignant tumors is well known, their asso…
Tohmina Akhter, Shahana Pervin, Annekathryn Goodman
Background: Ovarian cancer accounts for 4% of cancers occurring in women and ranks first in gynecological cancer mortality. Maintaining and improving quality of life is an important goal of cancer treatment. The toxicities of cancer treatment particularly che…
Wessam Elghamry, Ali Azmy, Iman Fouad, Zeinab Elsayed, Sherif Abdelwahab
Background : The optimal TRT dose/fraction for LD-SCLC remains debatable, and due to increasing number of population in Egypt and number of patients as well, so reducing the duration of radiation therapy is favored. This study was conducted using etoposide an…
Asmaa El Desoky, Hosny Badrawy, Dina Ismail Abd El Razik, Khaled F. Riad, Omina N. Abdelhamid, Eman Hassan
Background: Acute lymphoblastic leukemia (ALL), a common pediatric malignant neoplasia, showed high relapse rate after induction therapy. Some miRNAs have been shown to regulate normal hematopoiesis and their disruption could contribute to leukemogenesis: Rec…
Ye Nong Tan, Xiaoqin Wu, Shufang Li, Xiang Wang, Guoqing Fu, Liu Xie, Yisha Wu, Qingyan Han
Objective: To investigate the protein expression and clinicopathological characteristics of ABCG2 , Oct4 , Nanog in laryngeal cancer tissues, and to seek new molecular markers for the diagnosis of laryngeal cancer. Methods: The laryngeal cancer tissues and pa…
Bobby Varghese, Navid Darayan, Cristiana Rastellini, Luca Cicalese, Mauro Montalbano, 1 1
Immunotherapy is one of the strategies to boost natural defenses to fight cancer. Immuno-oncology is an artificial stimulation of the human immune system to recognize and kill selectively neoplastic cells at different stage of transformation. Cancer cells hav…
Cátia Fava Gaspar, Maria João Leitão, Manuela Machado
Cutaneous presentation of gastric cancer is very rare. This case report is about a patient with a metastatic gastric cancer in which the diagnosis was made by a cutaneous biopsy. Following this unusual diagnostic tool, the patient had an intracardiac thrombus…
Mouhamadou Bachir Ba, Amadou Ibra Diallo, Fatimatou Néné Sarr, El Hadji Aliou Baldé, Ibrahima Thiam, Papa Macoumba Gaye
Aim: We endeavored to describe the epidemiological profile of prostatic cancer, and to evaluate its diagnostic and therapeutic aspects. Method: We conducted a descriptive retrospective study on the conformational radiotherapy of prostatic adenocarcinoma at th…
B. E. Cham
Background: There is ample evidence to support the safety and efficacy of the topical anticancer cream Curaderm in the treatment of non-melanoma skin cancers. Curaderm contains the natural glycoalkaloid solamargine in the form of BEC, which has been establish…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).